Effect of sitagliptin monotherapy on serum total ghrelin levels in people with type 2 diabetes

ÖZ GÜL Ö., Kiyici S., ERSOY C., CANDER S., Yorulmaz H., Gul C. B., ...More

DIABETES RESEARCH AND CLINICAL PRACTICE, vol.94, no.2, pp.212-216, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 94 Issue: 2
  • Publication Date: 2011
  • Doi Number: 10.1016/j.diabres.2011.07.031
  • Journal Name: DIABETES RESEARCH AND CLINICAL PRACTICE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.212-216
  • Keywords: Sitagliptin, Diabetes mellitus type 2, Ghrelin, Body weight, INCRETIN-BASED THERAPIES, CIRCULATING GHRELIN, INSULIN THERAPY, WEIGHT-GAIN, METFORMIN, INHIBITOR, STOMACH, PEPTIDE
  • Bursa Uludag University Affiliated: Yes

Abstract

Aim: Sitagliptin is not associated with weight gain and has neutral effects on body weight. It is unclear whether sitagliptin treatment alters serum ghrelin levels in people with type 2 diabetes.